Management of Poor Responders
Endocrine: FSH Estradiol AMH Sonographic: AFC Previous history: Age Endometriosis, pelvic surgery The woman’s age would be a constant parameter to define a candidate patient for low response. In our…
The Importance of Isoflavones for Women’s Health
Fig. 22.1 Endoplasmatic reticulum and gene expression 22.3 Epidemiological Data That Demonstrate the Safety of Isoflavones Alongside a large number of experimental facts that suggest the chemoprotective effect of isoflavones,…
Metabolic Healthy Obesity and Metabolic Obesity with Normal Weight and CVD Risk in Women
Fig. 14.1 Abdominal to gynoid deposit ratio (A/G ratio) in different obesity phenotypes of postmenopausal women. Abbreviations: MONW, metabolic obesity with normal weight; MHO, metabolic healthy obesity; OWMD, obesity with…
Luteal-Phase Stimulation
Author Patients Treatment Oocytes recovered LPS FPS LPS FPS von Wolff et al. [22] 12 28 rFSH-Antag 8.5 11.5 Bedoschi et al. [4] 2 rFSH-Antag 12 Maman (2010) [16] 5…
Medical Treatment of Myomas
Fig. 17.1 Estrogen and progesterone modulation of fibroid growth 17.3 Medical Treatment of Fibroids The only treatment for fibroids that has been considered is myomectomy or hysterectomy or, in some…
Body Identical Hormone Replacement: The Way Forward?
© International Society of Gynecological Endocrinology 2016Andrea R. Genazzani and Basil C. Tarlatzis (eds.)Frontiers in Gynecological EndocrinologyISGE Series10.1007/978-3-319-23865-4_24 24. Body Identical Hormone Replacement: The Way Forward? Nicholas Panay1 (1) Department of West London Menopause Service, Queen…
Gender-Specific Hypertension
Glucose increase Insulin resistance Increase in diastolic blood pressure Hyperlipidemia Vasoconstriction Changes in smooth muscle cells of blood vessels Changes in collagen content Atrial cardiomyocytes have phenotype partly that of…
The Aging Brain in Women: Impact of Steroid Replacement Therapies
© International Society of Gynecological Endocrinology 2016Andrea R. Genazzani and Basil C. Tarlatzis (eds.)Frontiers in Gynecological EndocrinologyISGE Series10.1007/978-3-319-23865-4_20 20. The Aging Brain in Women: Impact of Steroid Replacement Therapies Andrea R. Genazzani1, 2 and Nicola Pluchino2 (1) Obstetrics…
Management of Symptoms During the Menopausal Transition
Progestin Half-life (hours) Equivalent dose Cyproterone acetate 48 1 mg Nomegestrol acetate 30–50 (1.5) 2.5–5 mg Chlormadinone acetate 34–39 3 mg Drospirenone 30 3 mg NETA 8–26 (1) 2.5–5 mg…
Premature Ovarian Insufficiency: Advances in Management Through a Global Registry
© International Society of Gynecological Endocrinology 2016Andrea R. Genazzani and Basil C. Tarlatzis (eds.)Frontiers in Gynecological EndocrinologyISGE Series10.1007/978-3-319-23865-4_7 7. Premature Ovarian Insufficiency: Advances in Management Through a Global Registry Nicholas Panay1 (1) Department of West London…
